Hypercalcitoninemia and Insulinoma – a rare association

Calcitonin is a crucial biochemical marker used in the monitoring of patients with medullary thyroid carcinoma. However increased levels of circulating calcitonin may also be associated with other clinical conditions, namely pancreatic neuroendocrine tumours (PanNETs). The incidence of calcitonin secretion by these tumours is unknown. We describe a case of a 72-year-old man who presented with lipothymia and paraesthesias of the mouth and hands associated with severe pre-prandial hypoglycaemia. Diagnostic work-up revealed an insulinoma with immunostaining for calcitonin. It is worth to mention that a subjacent hypercalcitoninemia was found. Additionally, we perform a review of the related literature. Our case highlights a very rare cause of hypercalcitoninemia and the need for a better understanding on the implications of calcitonin secretion by PanNETs. Hypercalcitoninemia and Insulinoma: A Rare Association

[1]  F. Sessa,et al.  Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature , 2017, Endocrine Pathology.

[2]  Seung‐Mo Hong,et al.  Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts. , 2016, Archives of pathology & laboratory medicine.

[3]  V. Hervieu,et al.  Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up. , 2016, European journal of endocrinology.

[4]  A. Lenzi,et al.  Extrathyroidal Calcitonin Secreting Tumors: Pancreatic Neuroendocrine Tumors in Patients With Multinodular Goiter , 2016, Medicine.

[5]  G. Kaltsas,et al.  Pancreatic Neuroendocrine Tumors Presenting with Hypercalcitonemia , 2015 .

[6]  Douglas B. Evans,et al.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.

[7]  A. Grossman,et al.  Paraneoplastic Syndromes related to Neuroendorine Tumours , 2013 .

[8]  J. Bilezikian,et al.  Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.

[9]  V. Fendrich,et al.  Calcitonin-Secreting Pancreatic Endocrine Tumors: Systematic Analysis of a Rare Tumor Entity , 2011, Pancreas.

[10]  R. Moll,et al.  Differentiation between Thyroidal and Ectopic Calcitonin Secretion in patients with Coincidental Thyroid Nodules and Pancreatic Tumors – A Report of Two Cases , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[11]  S. Toledo,et al.  Hypercalcitoninemia is not Pathognomonic of Medullary Thyroid Carcinoma , 2009, Clinics.

[12]  Sebastiano Filetti,et al.  Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls , 2009, Nature Clinical Practice Endocrinology &Metabolism.

[13]  M. Maranghi,et al.  Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. , 2007, The Journal of clinical endocrinology and metabolism.

[14]  K. Rácz,et al.  Hypercalcitoninemia in a patient with a recurrent goitre and insulinoma: a case report. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[15]  C. Dervenis,et al.  Asymptomatic calcitonin-secreting tumor of the pancreas. A case report. , 2006, JOP : Journal of the pancreas.

[16]  Rajiv C. Shah,et al.  Calcitonin-Secreting Tumor of the Pancreas , 2004, Digestive Surgery.

[17]  A. Grossman,et al.  The diagnosis and medical management of advanced neuroendocrine tumors. , 2004, Endocrine reviews.

[18]  R. Hinze,et al.  Hypercalcitoninemia in a Sporadic Asymptomatic Neuroendocrine Tumor of the Pancreatic Tail , 2000, Digestive Surgery.

[19]  A. Sauvanet,et al.  Calcitonin‐Secreting Tumors of the Pancreas: About Six Cases , 1998, Pancreas.

[20]  C. Verhagen,et al.  Pancreatic islet cell tumor producing vasoactive intestinal polypeptide and calcitonin. , 1997, Anticancer research.

[21]  F. Gesek,et al.  Cellular calcium transport in renal epithelia: measurement, mechanisms, and regulation. , 1995, Physiological reviews.

[22]  L. Sobrinho,et al.  Calcitonin‐producing insulinoma: clinical, immunocytochemical and cytogenetical study , 1994, Clinical endocrinology.

[23]  B. Poulet,et al.  [Pancreatic insulinoma, adenomatosis of the Wirsung's duct and chronic pancreatitis. Apropos of a case]. , 1993, Archives d'anatomie et de cytologie pathologiques.

[24]  D. Price,et al.  A case of multiple endocrine neoplasia: hyperparathyroidism, insulinoma, GRF‐oma, hypercalcitoninaemia and intractable peptic ulceration , 1992, Clinical endocrinology.

[25]  D. Ballard,et al.  Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. , 1991, Mayo Clinic proceedings.

[26]  B. Thomson,et al.  The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. , 1985, Endocrinology.

[27]  F. Sundler,et al.  Neurohormonal peptides in endocrine tumors of the pancreas, stomach, and upper small intestine: I. An immunohistochemical study of 27 cases. , 1983, Ultrastructural pathology.

[28]  T. Adrian,et al.  Pancreatic polypeptide and calcitonin secretion from a pancreatic tumour-clinical improvement after hepatic artery embolization. , 1983, Postgraduate medical journal.